Journal article
REDUCTION IN FIRST AND RECURRENT CARDIOVASCULAR AND ISCHEMIC EVENTS WITH TICAGRELOR COMPARED WITH CLOPIDOGREL IN THE PLATO STUDY
Journal of the American College of Cardiology, v 59(13), pp E504-E504
27 Mar 2012
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Background We sought to explore the effect of potent platelet inhibition on recurrent (e.g. second) and ischemic events, such as urgent revascularization (Urgent Revasc), (severe) recurrent ischemia (SRI/RI), transient ischemic attacks (TIA) and arterial thromboses (ATE).
Metrics
1 Record Views
Details
- Title
- REDUCTION IN FIRST AND RECURRENT CARDIOVASCULAR AND ISCHEMIC EVENTS WITH TICAGRELOR COMPARED WITH CLOPIDOGREL IN THE PLATO STUDY
- Creators
- Payal Kohli - Thrombolysis in Myocardial Infarction Study GroupLars Wallentin - Thrombolysis in Myocardial Infarction Study GroupEric Reyes - Thrombolysis in Myocardial Infarction Study GroupJay Horrow - Thrombolysis in Myocardial Infarction Study GroupSteen Husted - Thrombolysis in Myocardial Infarction Study GroupRobert Storey - Thrombolysis in Myocardial Infarction Study GroupStefan James - Thrombolysis in Myocardial Infarction Study GroupChristopher Cannon - Thrombolysis in Myocardial Infarction Study Group
- Publication Details
- Journal of the American College of Cardiology, v 59(13), pp E504-E504
- Publisher
- Elsevier Limited
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Anesthesiology and Perioperative Medicine
- Web of Science ID
- WOS:000302326700505
- Other Identifier
- 991020785757404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Cardiac & Cardiovascular Systems